M. Boyd

Inga fler pågående positioner

Förmögenhet: 100 849 $ per 2026-06-30

46 år

4 relationer

Health Technology

Finance

Consumer Services

Profil

M.
Cantey Boyd is an Independent Director at Kiniksa Pharmaceuticals International Plc since 2024.
Former positions include Director at Aquinox Pharmaceuticals, Inc., Director and Independent Director at Neoleukin Therapeutics, Inc., and Principal at Baker Bros.
Advisors LP.
Education includes undergraduate studies at Brown University.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
0 %	2026-04-06	1 577 ( 0 % )	100 849 $	2026-06-30

Aktiva positioner av M. Boyd

Företag	Position	Start

Alla aktiva positioner av M. Boyd

Tidigare kända positioner av M. Boyd

Företag	Position	Slut
NEUROGENE INC.	Direktör/Styrelseledamot	-
Neoleukin Therapeutics, Inc. /old/ Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives	Direktör/Styrelseledamot	-
Aquinox Pharmaceuticals, Inc. Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer	Direktör/Styrelseledamot	-
Baker Bros. Advisors LP Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.	Analyst-Equity	-

Se detaljerna i M. Boyds erfarenhet

M. Boyds utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i M. Boyds erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
Baker Bros. Advisors LP Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.	Finance
Brown University Brown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aquinox Pharmaceuticals, Inc. Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer	Health Technology
Neoleukin Therapeutics, Inc. /old/ Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives	Health Technology
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity	Health Technology